Apellis Pharmaceuticals (APLS) PT Raised to $41 at Barclays

March 31, 2026 12:23 PM

Barclays analyst Eliana Merle raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found